Literature DB >> 18772164

Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.

Mauro Biffi1, Matteo Ziacchi, Matteo Bertini, Diego Sangiorgi, Daniela Corsini, Cristian Martignani, Igor Diemberger, Giuseppe Boriani.   

Abstract

AIMS: Comparative studies on the longevity of implantable cardioverter-defibrillators (ICDs) among different manufacturers have never been reported. Longevity of ICD devices implanted from 1 January 2000 to 31 December 2002 was prospectively investigated according to their type and manufacturer. METHODS AND
RESULTS: Longevity of single-chamber (SC), double-chamber (DC), and biventricular (CRT-D) ICDs from Medtronic (MDT), Guidant (GDT), and St Jude Medical (SJM) was measured in all the patients who required device replacement. The observation follow-up ended on 31 December 2007; patients who died prematurely or were transplanted before battery exhaustion were excluded from the analysis. Factors associated with longevity (number of delivered shocks, pacing activity) were researched. One hundred and fifty-three patients received an ICD in the abovementioned period. Six underwent heart transplantation, and 23 died before device replacement; 80 had an SC device, 59 had DC device, and 14 had CRT-D device. Longevity of MDT was superior to GDT and SJM, replacement rates being, respectively, 42%, 95.3%, and 97.2%. Only MDT manufacturers and SC type were associated with greater ICD longevity. Longevity had an impact on the cost/month of treatment of replaced ICDs.
CONCLUSION: Battery longevity is significantly different among manufacturers. ICD cost is strictly dependent on device longevity, whereas device up-front cost is of limited clinical meaning. Appropriate assessment of cost-effectiveness should be based on ICD longevity in the real-life scenario.

Entities:  

Mesh:

Year:  2008        PMID: 18772164     DOI: 10.1093/europace/eun240

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

1.  Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs).

Authors:  Tali Shafat; Yael Baumfeld; Victor Novack; Yuval Konstantino; Guy Amit
Journal:  Clin Res Cardiol       Date:  2012-07-14       Impact factor: 5.460

Review 2.  Electrical cardioversion of patients with implanted pacemaker or cardioverter-defibrillator: results of a survey of german centers and systematic review of the literature.

Authors:  J Lüker; A Sultan; T Plenge; J van den Bruck; C-H Heeger; S Meyer; K Mischke; R R Tilz; D Vollmann; G Nölker; B Schäffer; S Willems; D Steven
Journal:  Clin Res Cardiol       Date:  2017-11-18       Impact factor: 5.460

3.  The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries.

Authors:  Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2015-02-19       Impact factor: 5.460

4.  "Real life" longevity of implantable cardioverter-defibrillator devices.

Authors:  Antonis S Manolis; Themistoklis Maounis; Spyridon Koulouris; Vassilios Vassilikos
Journal:  Clin Cardiol       Date:  2017-05-22       Impact factor: 2.882

5.  Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.

Authors:  Maurizio Landolina; Antonio Curnis; Giovanni Morani; Antonello Vado; Ernesto Ammendola; Antonio D'onofrio; Giuseppe Stabile; Martino Crosato; Barbara Petracci; Carlo Ceriotti; Luca Bontempi; Martina Morosato; Gian Paolo Ballari; Maurizio Gasparini
Journal:  Europace       Date:  2015-05-14       Impact factor: 5.214

6.  Seven years of use of implantable cardioverter-defibrillator therapies: a nationwide population-based assessment of their effectiveness in real clinical settings.

Authors:  Arn Migowski; Antonio Luiz Ribeiro; Marilia Sá Carvalho; Vitor Manuel Pereira Azevedo; Rogério Brant Martins Chaves; Lucas de Aquino Hashimoto; Carolina de Aquino Xavier; Regina Maria de Aquino Xavier
Journal:  BMC Cardiovasc Disord       Date:  2015-03-13       Impact factor: 2.298

7.  Longevity of implantable cardioverter-defibrillators in a single-center population.

Authors:  Joachim Seegers; Pascal Muñoz Expósito; Lars Lüthje; Thomas Fischer; Matthias Lueken; Hannes Wenk; Samuel T Sossalla; Gerd Hasenfuss; Markus Zabel
Journal:  J Interv Card Electrophysiol       Date:  2015-08-08       Impact factor: 1.900

8.  Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.

Authors:  Paolo Zanaboni; Maurizio Landolina; Maurizio Marzegalli; Maurizio Lunati; Giovanni B Perego; Giuseppe Guenzati; Antonio Curnis; Sergio Valsecchi; Francesca Borghetti; Gabriella Borghi; Cristina Masella
Journal:  J Med Internet Res       Date:  2013-05-30       Impact factor: 5.428

Review 9.  Development of implantable medical devices: from an engineering perspective.

Authors:  Yeun-Ho Joung
Journal:  Int Neurourol J       Date:  2013-09-30       Impact factor: 2.835

10.  Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.

Authors:  Simon von Gunten; Beat A Schaer; Sing-Chien Yap; Tamas Szili-Torok; Michael Kühne; Christian Sticherling; Stefan Osswald; Dominic A M J Theuns
Journal:  Europace       Date:  2015-11-25       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.